[An experimental evaluation of the attenuated strain 15 of the Venezuelan equine encephalomyelitis virus].
Explore the source record for details and available documents.
Animals↗
Biomedical subjects
N K Chernikova
Publications and source records attributed to N K Chernikova.
[A method of fluorescent immunoenzyme analysis in the complex evaluation of viral and rickettsial vaccines].
With the use of the unified indirect solid-phase fluorescent enzyme immunoassay the combined evaluation of the antigenic and immunogenic properties of experimental whole-virion inactivated virus vaccines against Venezuelan and eastern equine encephalomyelitides, as well as of dried chemical typhus vaccine, has been made; their safety was determined indirectly by the content of ovalbumin. The protective role of antibodies evaluated by the solid-phase fluorescent enzyme immunoassay in typhus immunity has been shown.
Animals↗
[The evaluation in hamadryas baboons of the possibility for the specific prevention of Ebola fever].
The protective role of virus-neutralizing antibody was demonstrated in Ebola virus-infected animals (Papio hamadryas) used in experiments on the development of passive humoral immunity by using specific immunoglobulin. Two immunizations of the monkeys with purified concentrated Ebola virus antigen with complete Freund adjuvant was shown to confirm intensive immunity to subsequent challenge protecting 80% of the immunized animals. It is concluded that effective preparations may be developed for specific prophylaxis of Ebola fever.
Animals↗
[The duration of humoral postvaccinal and postinfection immunity to the Venezuelan equine encephalomyelitis virus].
Serological studies on the levels of virus-neutralizing antibodies (VNA) against Venezuelan equine encephalomyelitis virus (VEE) were carried out by the standard method in 280 human subjects given a single primary inoculation of experimental forms of live vaccines against VEE prepared from attenuated strains No. 15 and No. 230. The VNA were found to persist in the blood of the vaccinees for 5-25 years (the observation period) from the time of vaccination practically at the same level. The VNA titres did not depend on the form of the preparation (for subcutaneous or oral administration) used for immunization. Similar studies were carried out on sera from 17 convalescents after VEE experienced in the past. An identical result was obtained. It is suggested that immunity to VEE persists for life.
Antibodies, Viral↗
[Development and study of immunoglobulins against Lassa fever].
The authors validate the use of horses as producers of immune antiserum to Lassa virus. Specific immunoglobulin with at least 1:512 titer of virus neutralizing antibodies to Lassa virus was obtained from the serum of immunized horses by Kohn's alcohol method. The resultant preparation does not differ from the heterologous commercial immunoglobulins. Preclinical studies of immunoglobulin against Lassa virus demonstrated its safety and high specific activity. The strategy of treating with the immunoglobulin alone and in combination with virasol has been experimentally validated.
Animals↗
[Development and study of properties of immunoglobulins against Lassa fever].
A horse may serve the producer of immune antiserum to Lassa virus. Specific immunoglobulin with at least 1:512 titer of virus-neutralizing antibodies to Lassa fever was obtained by alcohol sedimentation after Cohn from the blood serum of immunized horses. The preparation does not differ from heterologous commercial immunoglobulins. Preclinical studies of immunoglobulin to Lassa fever demonstrated its safety and a high specific activity. The agent can be injected both alone and in combination with virasole.
Animals↗
[Methodical principles for testing tableted viral preparations].
Presents the methods of oral and enteral administration of vaccines in tablets. Describes the method of oral administration with a sponge and the technique of administering large and small tablets in the intestinal tract. Describes the specific features of administering tablets to mice, guinea pigs, rabbits, and monkeys.
Administration, Oral↗